Insulin resistance in chronic hepatitis B and C
MetadataShow full item record
Aim: To determine whether insulin resistance occurs in patients with chronic hepatitis B (CHB) and chronic hepatitis C (CHC), and its relationship with the presence of liver fibrosis and steatosis. Methods: Untreated patients with CHC (n=60) or CHB (n=40), similar in age, gender, body mass index and waist-hip ratio, were studied. Relationship between anthropometric, biochemical (fasting serum insulin, C-peptide, ferritin, iron, TNF-?, cholesterol, triglyceride, bilirubin, hemoglobin, and platelet concentrations) and liver biopsy (43 CHC and 20 CHB patients) findings was investigated by insulin resistance determined via the homeostasis model assessment (HOMA-IR). Results: The mean fasting serum insulin was 14.9 (11.9) mU/mL in CHC and 21.4 (17.4) in the CHB group (normal range 0.7-9; p=0.049) and mean HOMA-IR was 3.1 (2.6) in CHC versus 4.7 (4.1) in the CHB group (normal range 0.12-4.61; p=0.036) . HOMA-IR was significantly associated with fibrosis stage in the CHC group (p=0.015), but not in the CHB group. Conclusion: Hyperinsulinemia occurs in chronic viral hepatitis B and hepatitis C; insulin resistance is associated with stage of fibrosis in hepatitis C. Copyright é 2006 by Indian Society of Gastroenterology.
Showing items related by title, author, creator and subject.
The effects of legumes on metabolic features, insulin resistance and hepatic function tests in women with central obesity: A randomized controlled trial Alizadeh, M; Gharaaghaji, R; Pourghassem Gargari, B (2014)Background: The effect of high-legume hypocaloric diet on metabolic features in women is unclear. This study provided an opportunity to find effects of high-legume diet on metabolic features in women who consumed high ...
Rafeey, M; Kianrad, M; Hasani, A (2007)Objective: To evaluate the clinical and para-clinical presentation, including autoantibody pattern, and response to treatment in Iranian children with autoimmune hepatitis (AIH). Methods: Data of 60 children presenting ...
Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation Noori, M; Jafari, B; Hekmatdoost, A (2017)BACKGROUND: The effects of pomegranate juice (PJ) on the risk factors of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) have been reported previously; however, the effects on NAFLD and its ...